Italy’s new prime minister defended discredited stem cell therapy – Science Magazine
Science Magazine |
Italy’s new prime minister defended discredited stem cell therapy
Science Magazine Conte, a civil law professor at the University of Florence in Italy with no previous political experience, helped a family win the right to try a discredited stem cell treatment that caused a major uproar in Italy 5 years ago. There are also questions … |
Brooks in Beta (press release) (blog) |
Stem Cell Banking Market 2018-2023 – Major Players are Cord Blood Registry Systems, Cordlife Group Limited and …
PR Newswire (press release) The “Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application – Global Forecasts to 2023 ” report has been added to ResearchAndMarkets.com’s offering. Global Stem Cell Media Market Competitive Insights 2018: Lonza, Merck Millipore, GE Healthcare and Miltenyi BiotecExclusive Reportage Global Stem Cell Media Market 2018 – Thermo Fisher, STEMCELL Technologies, Merck Millipore, Lonza, GE HealthcareBrooks in Beta (press release) (blog) Stem Cell Banking Market by Source, Service Type, Application – Global Forecasts to 2023 – ResearchAndMarkets.comDigital Journal Expert Consulting –News Guards (blog) all 345 news articles » |
Indianapolis Business Journal |
Gene therapies that could transform diseases get easier FDA path
Indianapolis Business Journal New therapies that could cure diseases caused by defective genes will get a faster path to approval by U.S. regulators, part of an effort by the Food and Drug Administration to keep pace with one of biotechnology’s fastest-growing fields. Unlike … |
|
Monitoring Immunotherapy’s Side Effects in Genitourinary Cancers
Curetoday.com While immunotherapy agents are generally well-tolerated, it is important that patients with genitourinary cancers know what kind of side effects to look out for, and when they should contact their health care providers about them. While patients may be … |